Concepedia

John F. Beattie

JF

2

Publications

202

Citations

2

H-Index

2003

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

John F. Beattie is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicinal chemistry, and natural sciences.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryBiochemistryPharmacotherapyChemical BiologyDrug DevelopmentRadiation Oncology

Publications per year

2003–2003

2

Publications

2

Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation

Malcolm Anderson, John F. Beattie, Gloria A. Breault et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 114 citations · Full text

Cyclin-dependent Kinase Inhibitors, Medicinal Chemistry, Bioorganic Chemistry +10

Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimisation of substituted 4,6-Bis anilino pyrimidines

John F. Beattie, Gloria A. Breault, Rebecca Ellston et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 88 citations · Full text

Medicinal Chemistry, Cyclin-dependent Kinase 4, Medicine +9

Rows per page

1–2 of 2